During Ozempic clinical trials for type 2 diabetes treatment, constipation was a side effect reported by 3% to 5% of participants
Inpatient use of continuous glucose monitoring to improve hyperglycemia
As dentists and healthcare providers increasingly encounter patients using weight loss medications, a pattern of oral side effects is emerging
Lilly has signaled its plans to submit tirzepatide to the FDA, potentially leading to competition between tirzepatide and semaglutide in the obesity and type 2 diabetes treatment markets
Serious side effects of semaglutide include: 1 Inflammation of the pancreas (pancreatitis) Gallbladder problems, including gallstones Increased risk of low blood sugar (hypoglycemia), especially in patients with type 2 diabetes Jaundice (yellow skin) Kidney problems (kidney failure) Serious allergic reactions Change in vision in people with type 2 diabetes Increased heart rate Depression or thoughts of suicide *All medications, including semaglutide, can cause side effects which can be mild or serious
I2 = 0) and diarrhea by 166%
